Last 12 months
Inside the activity.
0 purchase rows · 7 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 1 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 1 |
| Jun 2026 | 0 | 1 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 2 |
| Sep 2026 | 0 | 2 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 30, 2024 Filed Apr 2, 2024 21:22 UTC |
Bolton StephaniePresident, Global Epilepsy
|
GrantPerformance Stock Units · Derivative | 2,457 | $0.00 | $0.00 |
DisclosureSEC source: 0001639691-24-000049 · wk-form4_1712107347.xml · derivative · entry 12 Bolton Stephanie · CIK 0002012558 · President, Global Epilepsy 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,457 Underlying: Ordinary Shares · 2,457 shares Expires not disclosed F14 · derivative.exercise_price: Each performance stock unit (PSU) represents a contingent right to receive one Ordinary Share of the Company in accordance with the terms of the 2022 Plan and the award agreement. F16 · derivative.exercise_date: On March 30, 2024, reporting person was granted PSUs to vest or lapse on March 30, 2027 based on how the Company's ROIC calculated for the performance period 2024-2026 compares to a target determined by the 2022 Plan Administrator. The number included in column 5 of Table II reflects the target number of PSUs eligible for vesting subject to continued service during the vesting period and the award agreement. F16 · derivative.expiration_date: On March 30, 2024, reporting person was granted PSUs to vest or lapse on March 30, 2027 based on how the Company's ROIC calculated for the performance period 2024-2026 compares to a target determined by the 2022 Plan Administrator. The number included in column 5 of Table II reflects the target number of PSUs eligible for vesting subject to continued service during the vesting period and the award agreement. Read SEC document |
| March 30, 2024 Filed Apr 2, 2024 21:22 UTC |
Bolton StephaniePresident, Global Epilepsy
|
GrantPerformance Stock Units · Derivative | 2,457 | $0.00 | $0.00 |
DisclosureSEC source: 0001639691-24-000049 · wk-form4_1712107347.xml · derivative · entry 11 Bolton Stephanie · CIK 0002012558 · President, Global Epilepsy 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,457 Underlying: Ordinary Shares · 2,457 shares Expires not disclosed F14 · derivative.exercise_price: Each performance stock unit (PSU) represents a contingent right to receive one Ordinary Share of the Company in accordance with the terms of the 2022 Plan and the award agreement. F15 · derivative.exercise_date: On March 30, 2024, reporting person was granted PSUs to vest or lapse on March 30, 2027 based on how the Company's FCF for performance period 2024-2026 compares to a target determined by the 2022 Plan Administrator. The number included in column 5 of Table II reflects the target number of PSUs eligible for vesting subject to continued service during the vesting period and the award agreement. F15 · derivative.expiration_date: On March 30, 2024, reporting person was granted PSUs to vest or lapse on March 30, 2027 based on how the Company's FCF for performance period 2024-2026 compares to a target determined by the 2022 Plan Administrator. The number included in column 5 of Table II reflects the target number of PSUs eligible for vesting subject to continued service during the vesting period and the award agreement. Read SEC document |
| March 30, 2024 Filed Apr 2, 2024 21:22 UTC |
Bolton StephaniePresident, Global Epilepsy
|
GrantRestricted Stock Units · Derivative | 4,915 | $0.00 | $0.00 |
DisclosureSEC source: 0001639691-24-000049 · wk-form4_1712107347.xml · derivative · entry 10 Bolton Stephanie · CIK 0002012558 · President, Global Epilepsy 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,915 Underlying: Ordinary Shares · 4,915 shares Expires not disclosed F7 · derivative.exercise_price: Each RSU represents a contingent right to receive one Ordinary Share, in accordance with the terms of the LivaNova PLC 2022 Incentive Award Plan (the 2022 Plan) and the award agreement. F13 · derivative.exercise_date: On March 30, 2024, reporting person was granted RSUs subject to a four-year vesting in equal annual installments, the first vesting occurring on March 30, 2025. The RSUs are subject to forfeiture prior to vesting in accordance with the terms of the 2022 Plan and the award agreement. F13 · derivative.expiration_date: On March 30, 2024, reporting person was granted RSUs subject to a four-year vesting in equal annual installments, the first vesting occurring on March 30, 2025. The RSUs are subject to forfeiture prior to vesting in accordance with the terms of the 2022 Plan and the award agreement. Read SEC document |
| March 30, 2024 Filed Apr 2, 2024 21:22 UTC |
Bolton StephaniePresident, Global Epilepsy
|
Exercise / conversionPerformance Stock Units · Derivative | 1,961 | $0.00 | $0.00 |
DisclosureSEC source: 0001639691-24-000049 · wk-form4_1712107347.xml · derivative · entry 9 Bolton Stephanie · CIK 0002012558 · President, Global Epilepsy 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 1,961 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F9 · derivative.exercise_price: Each PSU represents a contingent right to receive one Ordinary Share of the Company in accordance with the terms of the 2015 Plan and the terms of the award agreement. F12 · derivative.exercise_date: On March 30, 2021, the reporting person was granted 1,706 PSUs. The vesting of the PSUs depended on the Company's performance against a target of the total shareholder return (TSR) for fiscal years 2021, 2022, and 2023, compared to peer companies. The Company's performance achieved a result of 115%, and the actual number of vested shares is presented as the quantity that was acquired. F12 · derivative.expiration_date: On March 30, 2021, the reporting person was granted 1,706 PSUs. The vesting of the PSUs depended on the Company's performance against a target of the total shareholder return (TSR) for fiscal years 2021, 2022, and 2023, compared to peer companies. The Company's performance achieved a result of 115%, and the actual number of vested shares is presented as the quantity that was acquired. Read SEC document |
| March 30, 2024 Filed Apr 2, 2024 21:22 UTC |
Bolton StephaniePresident, Global Epilepsy
|
Exercise / conversionPerformance Stock Units · Derivative | 1,290 | $0.00 | $0.00 |
DisclosureSEC source: 0001639691-24-000049 · wk-form4_1712107347.xml · derivative · entry 8 Bolton Stephanie · CIK 0002012558 · President, Global Epilepsy 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 1,290 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F9 · derivative.exercise_price: Each PSU represents a contingent right to receive one Ordinary Share of the Company in accordance with the terms of the 2015 Plan and the terms of the award agreement. F11 · derivative.exercise_date: On March 30, 2021, the reporting person received a grant of 853 PSUs. The number of PSUs that vested was the result of the Company's Return on Investment Capital (ROIC) for fiscal year 2021 with additional two years service condition. The performance achieved was 151.30%, and the actual number of vested shares is presented as the quantity that was acquired. F11 · derivative.expiration_date: On March 30, 2021, the reporting person received a grant of 853 PSUs. The number of PSUs that vested was the result of the Company's Return on Investment Capital (ROIC) for fiscal year 2021 with additional two years service condition. The performance achieved was 151.30%, and the actual number of vested shares is presented as the quantity that was acquired. Read SEC document |
| March 30, 2024 Filed Apr 2, 2024 21:22 UTC |
Bolton StephaniePresident, Global Epilepsy
|
Exercise / conversionPerformance Stock Units · Derivative | 1,706 | $0.00 | $0.00 |
DisclosureSEC source: 0001639691-24-000049 · wk-form4_1712107347.xml · derivative · entry 7 Bolton Stephanie · CIK 0002012558 · President, Global Epilepsy 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 1,706 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F9 · derivative.exercise_price: Each PSU represents a contingent right to receive one Ordinary Share of the Company in accordance with the terms of the 2015 Plan and the terms of the award agreement. F10 · derivative.exercise_date: On March 30, 2021, the reporting person received a grant of 853 PSUs. The number of PSUs that vested was the result of the Company's performance against a target related to Free Cash Flow (FCF) for fiscal year 2021 with additional two years service condition. The performance achieved was 200%, and the actual number of vested shares is presented as the quantity that was acquired. F10 · derivative.expiration_date: On March 30, 2021, the reporting person received a grant of 853 PSUs. The number of PSUs that vested was the result of the Company's performance against a target related to Free Cash Flow (FCF) for fiscal year 2021 with additional two years service condition. The performance achieved was 200%, and the actual number of vested shares is presented as the quantity that was acquired. Read SEC document |
| March 30, 2024 Filed Apr 2, 2024 21:22 UTC |
Bolton StephaniePresident, Global Epilepsy
|
Exercise / conversionRestricted Stock Units · Derivative | 1,330 | $0.00 | $0.00 |
DisclosureSEC source: 0001639691-24-000049 · wk-form4_1712107347.xml · derivative · entry 6 Bolton Stephanie · CIK 0002012558 · President, Global Epilepsy 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,989 Underlying: Ordinary Shares · 1,330 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_price: Each RSU represents a contingent right to receive one Ordinary Share, in accordance with the terms of the LivaNova PLC 2022 Incentive Award Plan (the 2022 Plan) and the award agreement. F8 · derivative.exercise_date: The reporting person was granted 5,319 RSUs on March 30, 2023, subject to a four-year vesting in equal annual installments, which began on March 30, 2024. The unvested RSUs reported here vest 25% on March 30, 2025, March 30, 2026, and March 30, 2027. The RSUs are subject to forfeiture prior to vesting in accordance with the terms of the 2022 Plan and the award agreement. F8 · derivative.expiration_date: The reporting person was granted 5,319 RSUs on March 30, 2023, subject to a four-year vesting in equal annual installments, which began on March 30, 2024. The unvested RSUs reported here vest 25% on March 30, 2025, March 30, 2026, and March 30, 2027. The RSUs are subject to forfeiture prior to vesting in accordance with the terms of the 2022 Plan and the award agreement. Read SEC document |
| March 30, 2024 Filed Apr 2, 2024 21:22 UTC |
Bolton StephaniePresident, Global Epilepsy
|
Exercise / conversionRestricted Stock Units · Derivative | 457 | $0.00 | $0.00 |
DisclosureSEC source: 0001639691-24-000049 · wk-form4_1712107347.xml · derivative · entry 5 Bolton Stephanie · CIK 0002012558 · President, Global Epilepsy 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 914 Underlying: Ordinary Shares · 457 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each RSU represents a contingent right to receive one Ordinary Share of the Company in accordance with the terms of the LivaNova PLC 2015 Incentive Award Plan (the 2015 Plan) and the award agreement. F6 · derivative.exercise_date: The reporting person was granted 1,828 RSUs on March 30, 2022, subject to a four-year vesting in equal annual installments, which began on March 30, 2023. The remaining unvested RSUs reported here vest 25% on March 30, 2025 and March 30, 2026. The RSUs are subject to forfeiture prior to vesting in accordance with the terms of the 2015 Plan and the award agreement. F6 · derivative.expiration_date: The reporting person was granted 1,828 RSUs on March 30, 2022, subject to a four-year vesting in equal annual installments, which began on March 30, 2023. The remaining unvested RSUs reported here vest 25% on March 30, 2025 and March 30, 2026. The RSUs are subject to forfeiture prior to vesting in accordance with the terms of the 2015 Plan and the award agreement. Read SEC document |
| March 30, 2024 Filed Apr 2, 2024 21:22 UTC |
Bolton StephaniePresident, Global Epilepsy
|
Exercise / conversionRestricted Stock Units · Derivative | 427 | $0.00 | $0.00 |
DisclosureSEC source: 0001639691-24-000049 · wk-form4_1712107347.xml · derivative · entry 4 Bolton Stephanie · CIK 0002012558 · President, Global Epilepsy 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 426 Underlying: Ordinary Shares · 427 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each RSU represents a contingent right to receive one Ordinary Share of the Company in accordance with the terms of the LivaNova PLC 2015 Incentive Award Plan (the 2015 Plan) and the award agreement. F5 · derivative.exercise_date: The reporting person was granted 1,706 RSUs on March 30, 2021, subject to a four-year vesting in equal annual installments, which began on March 30, 2022. The remaining unvested RSUs reported here vest 25% on March 30, 2025. The RSUs are subject to forfeiture prior to vesting in accordance with the terms of the 2015 Plan and the award agreement. F5 · derivative.expiration_date: The reporting person was granted 1,706 RSUs on March 30, 2021, subject to a four-year vesting in equal annual installments, which began on March 30, 2022. The remaining unvested RSUs reported here vest 25% on March 30, 2025. The RSUs are subject to forfeiture prior to vesting in accordance with the terms of the 2015 Plan and the award agreement. Read SEC document |
| March 30, 2024 Filed Apr 2, 2024 21:22 UTC |
Bolton StephaniePresident, Global Epilepsy
|
Exercise / conversionRestricted Stock Units · Derivative | 573 | $0.00 | $0.00 |
DisclosureSEC source: 0001639691-24-000049 · wk-form4_1712107347.xml · derivative · entry 3 Bolton Stephanie · CIK 0002012558 · President, Global Epilepsy 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 573 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each RSU represents a contingent right to receive one Ordinary Share of the Company in accordance with the terms of the LivaNova PLC 2015 Incentive Award Plan (the 2015 Plan) and the award agreement. F4 · derivative.exercise_date: The reporting person was granted 2,295 RSUs on March 30, 2020, subject to a four-year vesting in equal annual installments, which began on March 30, 2021. RSUs reported here vested 25% on March 30, 2024. The RSUs were subject to forfeiture prior to vesting in accordance with the terms of the 2015 Plan and the award agreement. F4 · derivative.expiration_date: The reporting person was granted 2,295 RSUs on March 30, 2020, subject to a four-year vesting in equal annual installments, which began on March 30, 2021. RSUs reported here vested 25% on March 30, 2024. The RSUs were subject to forfeiture prior to vesting in accordance with the terms of the 2015 Plan and the award agreement. Read SEC document |
| March 30, 2024 Filed Apr 2, 2024 21:22 UTC |
Bolton StephaniePresident, Global Epilepsy
|
Tax withholdingOrdinary Shares | 3,643 | $55.94 | $203,789.42 |
DisclosureSEC source: 0001639691-24-000049 · wk-form4_1712107347.xml · nonDerivative · entry 2 Bolton Stephanie · CIK 0002012558 · President, Global Epilepsy 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,562 F2 · shares: The referenced shares were withheld from distribution to satisfy tax liability. Read SEC document |
| March 30, 2024 Filed Apr 2, 2024 21:22 UTC |
Bolton StephaniePresident, Global Epilepsy
|
Exercise / conversionOrdinary Shares | 7,744 | $0.00 | $0.00 |
DisclosureSEC source: 0001639691-24-000049 · wk-form4_1712107347.xml · nonDerivative · entry 1 Bolton Stephanie · CIK 0002012558 · President, Global Epilepsy 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,205 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Reporting person had vested restricted stock units (RSUs) and performance stock units (PSUs) settled in Ordinary Shares of LivaNova PLC (the Company). Read SEC document |
| March 30, 2024 Filed Apr 3, 2024 01:21 UTC |
KOZY WILLIAM ADirector
|
GrantRestricted Stock Units · Derivative | 1,034 | $0.00 | $0.00 |
DisclosureSEC source: 0001639691-24-000048 · wk-form4_1712107304.xml · derivative · entry 1 KOZY WILLIAM A · CIK 0001221785 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,034 Underlying: Ordinary Shares · 1,034 shares Expires not disclosed F1 · derivative.exercise_price: Each RSU represents a contingent right to receive one Ordinary Share of LivaNova PLC (the Company) in accordance with the terms of the LivaNova PLC 2015 Incentive Award Plan (the 2015 Plan) and the award agreement. F2 · derivative.exercise_date: On March 30, 2024. reporting person was granted RSUs, in connection with resuming his position as a non-independent director, to vest and forfeiture restrictions thereon to lapse on March 30, 2025, subject to continued service during the vesting period and the award agreement. F2 · derivative.expiration_date: On March 30, 2024. reporting person was granted RSUs, in connection with resuming his position as a non-independent director, to vest and forfeiture restrictions thereon to lapse on March 30, 2025, subject to continued service during the vesting period and the award agreement. Read SEC document |
| March 30, 2024 Filed Apr 2, 2024 21:18 UTC |
Hutchinson Michael DamonChief Legal Officer
|
GrantStock Appreciation Rights · Derivative | 12,700 | $0.00 Strike: $55.94 | $0.00 |
DisclosureSEC source: 0001639691-24-000044 · wk-form4_1712107124.xml · derivative · entry 8 Hutchinson Michael Damon · CIK 0001606626 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,700 Underlying: Ordinary Shares · 12,700 shares Expires not disclosed F10 · derivative.exercise_date: On March 30, 2024, reporting person was granted stock appreciation rights (SARs) subject to a four-year vesting in equal annual installments, the first vesting occurring on March 30, 2025. The SARs are subject to forfeiture prior to vesting in accordance with the terms of the Plan and the award agreement. F10 · derivative.expiration_date: On March 30, 2024, reporting person was granted stock appreciation rights (SARs) subject to a four-year vesting in equal annual installments, the first vesting occurring on March 30, 2025. The SARs are subject to forfeiture prior to vesting in accordance with the terms of the Plan and the award agreement. Read SEC document |
| March 30, 2024 Filed Apr 2, 2024 21:18 UTC |
Hutchinson Michael DamonChief Legal Officer
|
GrantPerformance Stock Units · Derivative | 2,904 | $0.00 | $0.00 |
DisclosureSEC source: 0001639691-24-000044 · wk-form4_1712107124.xml · derivative · entry 7 Hutchinson Michael Damon · CIK 0001606626 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,904 Underlying: Ordinary Shares · 2,904 shares Expires not disclosed F6 · derivative.exercise_price: Each PSU represents a contingent right to receive one Ordinary Share of the Company in accordance with the terms of the 2022 Plan and the award agreement. F9 · derivative.exercise_date: On March 30, 2024, reporting person was granted PSUs to vest or lapse on March 30, 2027 based on how the Company's Return on Investment Capital (ROIC) calculated for the performance period 2024-2026 compares to a target determined by the 2022 Plan Administrator. The number included in column 5 of Table II reflects the target number of PSUs eligible for vesting subject to continued service during the vesting period and the award agreement. F9 · derivative.expiration_date: On March 30, 2024, reporting person was granted PSUs to vest or lapse on March 30, 2027 based on how the Company's Return on Investment Capital (ROIC) calculated for the performance period 2024-2026 compares to a target determined by the 2022 Plan Administrator. The number included in column 5 of Table II reflects the target number of PSUs eligible for vesting subject to continued service during the vesting period and the award agreement. Read SEC document |
| March 30, 2024 Filed Apr 2, 2024 21:18 UTC |
Hutchinson Michael DamonChief Legal Officer
|
GrantPerformance Stock Units · Derivative | 2,904 | $0.00 | $0.00 |
DisclosureSEC source: 0001639691-24-000044 · wk-form4_1712107124.xml · derivative · entry 6 Hutchinson Michael Damon · CIK 0001606626 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,904 Underlying: Ordinary Shares · 2,904 shares Expires not disclosed F6 · derivative.exercise_price: Each PSU represents a contingent right to receive one Ordinary Share of the Company in accordance with the terms of the 2022 Plan and the award agreement. F8 · derivative.exercise_date: On March 30, 2024, reporting person was granted PSUs to vest or lapse on March 30, 2027 based on how the Company's free cash flow (FCF) for performance period 2024-2026 compares to a target determined by the 2022 Plan Administrator. The number included in column 5 of Table II reflects the target number of PSUs eligible for vesting. F8 · derivative.expiration_date: On March 30, 2024, reporting person was granted PSUs to vest or lapse on March 30, 2027 based on how the Company's free cash flow (FCF) for performance period 2024-2026 compares to a target determined by the 2022 Plan Administrator. The number included in column 5 of Table II reflects the target number of PSUs eligible for vesting. Read SEC document |
| March 30, 2024 Filed Apr 2, 2024 21:18 UTC |
Hutchinson Michael DamonChief Legal Officer
|
GrantPerformance Stock Units · Derivative | 5,809 | $0.00 | $0.00 |
DisclosureSEC source: 0001639691-24-000044 · wk-form4_1712107124.xml · derivative · entry 5 Hutchinson Michael Damon · CIK 0001606626 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,809 Underlying: Ordinary Shares · 5,809 shares Expires not disclosed F6 · derivative.exercise_price: Each PSU represents a contingent right to receive one Ordinary Share of the Company in accordance with the terms of the 2022 Plan and the award agreement. F7 · derivative.exercise_date: On March 30, 2024, reporting person was granted PSUs to vest or lapse on March 30, 2027 based on the Company's total shareholder return (TSR) for the three-year period beginning on January 1, 2024 and ending December 31, 2026 relative to the TSR of an index of companies, as determined by the 2022 Plan Administrator. The number included in column 5 of Table II reflects the target number of PSUs eligible for vesting subject to continued service during the vesting period and the award agreement. F7 · derivative.expiration_date: On March 30, 2024, reporting person was granted PSUs to vest or lapse on March 30, 2027 based on the Company's total shareholder return (TSR) for the three-year period beginning on January 1, 2024 and ending December 31, 2026 relative to the TSR of an index of companies, as determined by the 2022 Plan Administrator. The number included in column 5 of Table II reflects the target number of PSUs eligible for vesting subject to continued service during the vesting period and the award agreement. Read SEC document |
| March 30, 2024 Filed Apr 2, 2024 21:18 UTC |
Hutchinson Michael DamonChief Legal Officer
|
GrantRestricted Stock Units · Derivative | 5,809 | $0.00 | $0.00 |
DisclosureSEC source: 0001639691-24-000044 · wk-form4_1712107124.xml · derivative · entry 4 Hutchinson Michael Damon · CIK 0001606626 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,809 Underlying: Ordinary Shares · 5,809 shares Expires not disclosed F3 · derivative.exercise_price: Each RSU represents a contingent right to receive one Ordinary Share of the Company in accordance with the terms of the LivaNova PLC 2022 Incentive Award Plan (the 2022 Plan) and the award agreement. F5 · derivative.exercise_date: On March 30, 2024, reporting person was granted RSUs subject to a four-year vesting in equal annual installments, the first vesting occurring on March 30, 2025. The RSUs are subject to forfeiture prior to vesting in accordance with the terms of the 2022 Plan and the award agreement. F5 · derivative.expiration_date: On March 30, 2024, reporting person was granted RSUs subject to a four-year vesting in equal annual installments, the first vesting occurring on March 30, 2025. The RSUs are subject to forfeiture prior to vesting in accordance with the terms of the 2022 Plan and the award agreement. Read SEC document |
| March 30, 2024 Filed Apr 2, 2024 21:18 UTC |
Hutchinson Michael DamonChief Legal Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 1,478 | $0.00 | $0.00 |
DisclosureSEC source: 0001639691-24-000044 · wk-form4_1712107124.xml · derivative · entry 3 Hutchinson Michael Damon · CIK 0001606626 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,432 Underlying: Ordinary Shares · 1,478 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each RSU represents a contingent right to receive one Ordinary Share of the Company in accordance with the terms of the LivaNova PLC 2022 Incentive Award Plan (the 2022 Plan) and the award agreement. F4 · derivative.exercise_date: On March 30, 2023, reporting person was granted RSUs subject to a four-year vesting in equal annual installments, the first vesting having occurred on March 30, 2024. The RSUs are subject to forfeiture prior to vesting in accordance with the terms of the 2022 Plan and the award agreement. F4 · derivative.expiration_date: On March 30, 2023, reporting person was granted RSUs subject to a four-year vesting in equal annual installments, the first vesting having occurred on March 30, 2024. The RSUs are subject to forfeiture prior to vesting in accordance with the terms of the 2022 Plan and the award agreement. Read SEC document |
| March 30, 2024 Filed Apr 2, 2024 21:18 UTC |
Hutchinson Michael DamonChief Legal Officer
|
Tax withholdingOrdinary Shares | 542 | $55.94 | $30,319.48 |
DisclosureSEC source: 0001639691-24-000044 · wk-form4_1712107124.xml · nonDerivative · entry 2 Hutchinson Michael Damon · CIK 0001606626 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,286 F2 · shares: The referenced shares were withheld from distribution to satisfy tax liability. Read SEC document |
| March 30, 2024 Filed Apr 2, 2024 21:18 UTC |
Hutchinson Michael DamonChief Legal Officer
|
Exercise / conversionOrdinary Shares | 1,478 | $0.00 | $0.00 |
DisclosureSEC source: 0001639691-24-000044 · wk-form4_1712107124.xml · nonDerivative · entry 1 Hutchinson Michael Damon · CIK 0001606626 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,828 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Reporting person had vested restricted stock units (RSUs) and vested performance stock units (PSUs) settled in Ordinary Shares of LivaNova PLC (the Company). Read SEC document |
| March 30, 2024 Filed Apr 3, 2024 01:21 UTC |
Hebbelinck TruiChief Human Resources Officer
|
GrantStock Appreciation Rights · Derivative | 8,792 | $0.00 Strike: $55.94 | $0.00 |
DisclosureSEC source: 0001639691-24-000047 · wk-form4_1712107272.xml · derivative · entry 14 Hebbelinck Trui · CIK 0001773051 · Chief Human Resources Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,792 Underlying: Ordinary Shares · 8,792 shares Expires not disclosed F18 · derivative.exercise_date: On March 30, 2024, reporting person was granted stock appreciation rights (SARs) subject to a four-year vesting in equal annual installments, the first vesting occurring on March 30, 2025. The SARs are subject to forfeiture prior to vesting in accordance with the terms of the 2022 Plan and the award agreement. F18 · derivative.expiration_date: On March 30, 2024, reporting person was granted stock appreciation rights (SARs) subject to a four-year vesting in equal annual installments, the first vesting occurring on March 30, 2025. The SARs are subject to forfeiture prior to vesting in accordance with the terms of the 2022 Plan and the award agreement. Read SEC document |
| March 30, 2024 Filed Apr 3, 2024 01:21 UTC |
Hebbelinck TruiChief Human Resources Officer
|
GrantPerformance Stock Units · Derivative | 4,022 | $0.00 | $0.00 |
DisclosureSEC source: 0001639691-24-000047 · wk-form4_1712107272.xml · derivative · entry 13 Hebbelinck Trui · CIK 0001773051 · Chief Human Resources Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,022 Underlying: Ordinary Shares · 4,022 shares Expires not disclosed F14 · derivative.exercise_price: Each performance stock unit (PSU) represents a contingent right to receive one Ordinary Share of the Company in accordance with the terms of the 2022 Plan and the award agreement. F17 · derivative.exercise_date: On March 30, 2024, reporting person was granted PSUs to vest or lapse on March 30, 2027 based on the Company's TSR for the three-year period beginning on January 1, 2024 and ending December 31, 2026 relative to the TSR of an index of companies, as determined by the 2022 Plan Administrator. The number included in column 5 of Table II reflects the target number of PSUs eligible for vesting subject to continued service during the vesting period and the award agreement. F17 · derivative.expiration_date: On March 30, 2024, reporting person was granted PSUs to vest or lapse on March 30, 2027 based on the Company's TSR for the three-year period beginning on January 1, 2024 and ending December 31, 2026 relative to the TSR of an index of companies, as determined by the 2022 Plan Administrator. The number included in column 5 of Table II reflects the target number of PSUs eligible for vesting subject to continued service during the vesting period and the award agreement. Read SEC document |
| March 30, 2024 Filed Apr 3, 2024 01:21 UTC |
Hebbelinck TruiChief Human Resources Officer
|
GrantPerformance Stock Units · Derivative | 2,011 | $0.00 | $0.00 |
DisclosureSEC source: 0001639691-24-000047 · wk-form4_1712107272.xml · derivative · entry 12 Hebbelinck Trui · CIK 0001773051 · Chief Human Resources Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,011 Underlying: Ordinary Shares · 2,011 shares Expires not disclosed F14 · derivative.exercise_price: Each performance stock unit (PSU) represents a contingent right to receive one Ordinary Share of the Company in accordance with the terms of the 2022 Plan and the award agreement. F16 · derivative.exercise_date: On March 30, 2024, reporting person was granted PSUs to vest or lapse on March 30, 2027 based on how the Company's Return on Investment Capital (ROIC) calculated for the performance period 2024-2026 compares to a target determined by the 2022 Plan Administrator. The number included in column 5 of Table II reflects the target number of PSUs eligible for vesting subject to continued service during the vesting period and the award agreement. F16 · derivative.expiration_date: On March 30, 2024, reporting person was granted PSUs to vest or lapse on March 30, 2027 based on how the Company's Return on Investment Capital (ROIC) calculated for the performance period 2024-2026 compares to a target determined by the 2022 Plan Administrator. The number included in column 5 of Table II reflects the target number of PSUs eligible for vesting subject to continued service during the vesting period and the award agreement. Read SEC document |
| March 30, 2024 Filed Apr 3, 2024 01:21 UTC |
Hebbelinck TruiChief Human Resources Officer
|
GrantPerformance Stock Units · Derivative | 2,011 | $0.00 | $0.00 |
DisclosureSEC source: 0001639691-24-000047 · wk-form4_1712107272.xml · derivative · entry 11 Hebbelinck Trui · CIK 0001773051 · Chief Human Resources Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,011 Underlying: Ordinary Shares · 2,011 shares Expires not disclosed F14 · derivative.exercise_price: Each performance stock unit (PSU) represents a contingent right to receive one Ordinary Share of the Company in accordance with the terms of the 2022 Plan and the award agreement. F15 · derivative.exercise_date: On March 30, 2024, reporting person was granted PSUs to vest or lapse on March 30, 2027 based on how the Company's free cash flow (FCF) for performance period 2024-2026 compares to a target determined by the 2022 Plan Administrator. The number included in column 5 of Table II reflects the target number of PSUs eligible for vesting subject to continued service during the vesting period and the award agreement. F15 · derivative.expiration_date: On March 30, 2024, reporting person was granted PSUs to vest or lapse on March 30, 2027 based on how the Company's free cash flow (FCF) for performance period 2024-2026 compares to a target determined by the 2022 Plan Administrator. The number included in column 5 of Table II reflects the target number of PSUs eligible for vesting subject to continued service during the vesting period and the award agreement. Read SEC document |
| March 30, 2024 Filed Apr 3, 2024 01:21 UTC |
Hebbelinck TruiChief Human Resources Officer
|
GrantRestricted Stock Units · Derivative | 4,022 | $0.00 | $0.00 |
DisclosureSEC source: 0001639691-24-000047 · wk-form4_1712107272.xml · derivative · entry 10 Hebbelinck Trui · CIK 0001773051 · Chief Human Resources Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,022 Underlying: Ordinary Shares · 4,022 shares Expires not disclosed F7 · derivative.exercise_price: Each RSU represents a contingent right to receive one Ordinary Share of the Company in accordance with the terms of the LivaNova PLC 2022 Incentive Award Plan (the 2022 Plan) and the award agreement. F13 · derivative.exercise_date: On March 30, 2024, reporting person was granted RSUs subject to a four-year vesting in equal annual installments, the first vesting occurring on March 30, 2025. The RSUs are subject to forfeiture prior to vesting in accordance with the terms of the 2022 Plan and the award agreement. F13 · derivative.expiration_date: On March 30, 2024, reporting person was granted RSUs subject to a four-year vesting in equal annual installments, the first vesting occurring on March 30, 2025. The RSUs are subject to forfeiture prior to vesting in accordance with the terms of the 2022 Plan and the award agreement. Read SEC document |
| March 30, 2024 Filed Apr 3, 2024 01:21 UTC |
Hebbelinck TruiChief Human Resources Officer
|
Exercise / conversionPerformance Stock Units · Derivative | 3,139 | $0.00 | $0.00 |
DisclosureSEC source: 0001639691-24-000047 · wk-form4_1712107272.xml · derivative · entry 9 Hebbelinck Trui · CIK 0001773051 · Chief Human Resources Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 3,139 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F9 · derivative.exercise_price: Each performance stock unit represents a contingent right to receive one Ordinary Share of the Company in accordance with the terms of the 2015 Plan and the award agreement. F12 · derivative.exercise_date: On March 30, 2021, the reporting person was granted 2,730 PSUs. The vesting of the PSUs depended on the Company's performance against a target of the total shareholder return (TSR) for fiscal years 2021, 2022, and 2023, compared to our peer companies. The Company's performance achieved a result of 115%, and the actual number of vested shares is presented as the quantity that was acquired. F12 · derivative.expiration_date: On March 30, 2021, the reporting person was granted 2,730 PSUs. The vesting of the PSUs depended on the Company's performance against a target of the total shareholder return (TSR) for fiscal years 2021, 2022, and 2023, compared to our peer companies. The Company's performance achieved a result of 115%, and the actual number of vested shares is presented as the quantity that was acquired. Read SEC document |
| March 30, 2024 Filed Apr 3, 2024 01:21 UTC |
Hebbelinck TruiChief Human Resources Officer
|
Exercise / conversionPerformance Stock Units · Derivative | 2,065 | $0.00 | $0.00 |
DisclosureSEC source: 0001639691-24-000047 · wk-form4_1712107272.xml · derivative · entry 8 Hebbelinck Trui · CIK 0001773051 · Chief Human Resources Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 2,065 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F9 · derivative.exercise_price: Each performance stock unit represents a contingent right to receive one Ordinary Share of the Company in accordance with the terms of the 2015 Plan and the award agreement. F11 · derivative.exercise_date: On March 30, 2021, the reporting person received a grant of 1,365 PSUs. The number of PSUs that vested was the result of the Company's Return on Investment Capital (ROIC) for fiscal year 2021 with additional two years service condition. The performance achieved was 151.30%, and the actual number of vested shares is presented as the quantity that was acquired. F11 · derivative.expiration_date: On March 30, 2021, the reporting person received a grant of 1,365 PSUs. The number of PSUs that vested was the result of the Company's Return on Investment Capital (ROIC) for fiscal year 2021 with additional two years service condition. The performance achieved was 151.30%, and the actual number of vested shares is presented as the quantity that was acquired. Read SEC document |
| March 30, 2024 Filed Apr 3, 2024 01:21 UTC |
Hebbelinck TruiChief Human Resources Officer
|
Exercise / conversionPerformance Stock Units · Derivative | 2,730 | $0.00 | $0.00 |
DisclosureSEC source: 0001639691-24-000047 · wk-form4_1712107272.xml · derivative · entry 7 Hebbelinck Trui · CIK 0001773051 · Chief Human Resources Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 2,730 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F9 · derivative.exercise_price: Each performance stock unit represents a contingent right to receive one Ordinary Share of the Company in accordance with the terms of the 2015 Plan and the award agreement. F10 · derivative.exercise_date: On March 30, 2021, the reporting person received a grant of 1,365 PSUs. The number of PSUs that vested was the result of the Company's performance against a target related to Free Cash Flow (FCF) for fiscal years 2021 with additional two years service condition. The performance achieved was 200%, and the actual number of vested shares is presented as the quantity that was acquired. F10 · derivative.expiration_date: On March 30, 2021, the reporting person received a grant of 1,365 PSUs. The number of PSUs that vested was the result of the Company's performance against a target related to Free Cash Flow (FCF) for fiscal years 2021 with additional two years service condition. The performance achieved was 200%, and the actual number of vested shares is presented as the quantity that was acquired. Read SEC document |
| March 30, 2024 Filed Apr 3, 2024 01:21 UTC |
Hebbelinck TruiChief Human Resources Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 1,330 | $0.00 | $0.00 |
DisclosureSEC source: 0001639691-24-000047 · wk-form4_1712107272.xml · derivative · entry 6 Hebbelinck Trui · CIK 0001773051 · Chief Human Resources Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,989 Underlying: Ordinary Shares · 1,330 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_price: Each RSU represents a contingent right to receive one Ordinary Share of the Company in accordance with the terms of the LivaNova PLC 2022 Incentive Award Plan (the 2022 Plan) and the award agreement. F8 · derivative.exercise_date: On March 30, 2023, reporting person was granted RSUs subject to a four-year vesting in equal annual installments, the first vesting occurring on March 30, 2024. The RSUs are subject to forfeiture prior to vesting in accordance with the terms of the 2022 Plan and the award agreement. F8 · derivative.expiration_date: On March 30, 2023, reporting person was granted RSUs subject to a four-year vesting in equal annual installments, the first vesting occurring on March 30, 2024. The RSUs are subject to forfeiture prior to vesting in accordance with the terms of the 2022 Plan and the award agreement. Read SEC document |
| March 30, 2024 Filed Apr 3, 2024 01:21 UTC |
Hebbelinck TruiChief Human Resources Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 685 | $0.00 | $0.00 |
DisclosureSEC source: 0001639691-24-000047 · wk-form4_1712107272.xml · derivative · entry 5 Hebbelinck Trui · CIK 0001773051 · Chief Human Resources Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,371 Underlying: Ordinary Shares · 685 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each RSU represents a contingent right to receive one Ordinary Share of the Company in accordance with the terms of the LivaNova PLC 2015 Incentive Award Plan (the 2015 Plan) and the award agreement. F6 · derivative.exercise_date: On March 30, 2022, reporting person was granted RSUs subject to a four-year vesting in equal annual installments, the first vesting for which occurred on March 30, 2023. The RSUs are subject to forfeiture prior to vesting in accordance with the terms of the 2015 Plan and the award agreement. F6 · derivative.expiration_date: On March 30, 2022, reporting person was granted RSUs subject to a four-year vesting in equal annual installments, the first vesting for which occurred on March 30, 2023. The RSUs are subject to forfeiture prior to vesting in accordance with the terms of the 2015 Plan and the award agreement. Read SEC document |
| March 30, 2024 Filed Apr 3, 2024 01:21 UTC |
Hebbelinck TruiChief Human Resources Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 683 | $0.00 | $0.00 |
DisclosureSEC source: 0001639691-24-000047 · wk-form4_1712107272.xml · derivative · entry 4 Hebbelinck Trui · CIK 0001773051 · Chief Human Resources Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 682 Underlying: Ordinary Shares · 683 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each RSU represents a contingent right to receive one Ordinary Share of the Company in accordance with the terms of the LivaNova PLC 2015 Incentive Award Plan (the 2015 Plan) and the award agreement. F5 · derivative.exercise_date: On March 30, 2021, reporting person was granted RSUs subject to a four-year vesting in equal annual installments, the first vesting for which occurred on March 30, 2022. The RSUs are subject to forfeiture prior to vesting in accordance with the terms of the 2015 Plan and the award agreement. F5 · derivative.expiration_date: On March 30, 2021, reporting person was granted RSUs subject to a four-year vesting in equal annual installments, the first vesting for which occurred on March 30, 2022. The RSUs are subject to forfeiture prior to vesting in accordance with the terms of the 2015 Plan and the award agreement. Read SEC document |
| March 30, 2024 Filed Apr 3, 2024 01:21 UTC |
Hebbelinck TruiChief Human Resources Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 1,147 | $0.00 | $0.00 |
DisclosureSEC source: 0001639691-24-000047 · wk-form4_1712107272.xml · derivative · entry 3 Hebbelinck Trui · CIK 0001773051 · Chief Human Resources Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 1,147 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each RSU represents a contingent right to receive one Ordinary Share of the Company in accordance with the terms of the LivaNova PLC 2015 Incentive Award Plan (the 2015 Plan) and the award agreement. F4 · derivative.exercise_date: On March 30, 2020, reporting person was granted RSUs subject to a four-year vesting in equal annual installments, the first vesting for which occurred on March 30, 2021. The RSUs were subject to forfeiture prior to vesting in accordance with the terms of the 2015 Plan and the award agreement. F4 · derivative.expiration_date: On March 30, 2020, reporting person was granted RSUs subject to a four-year vesting in equal annual installments, the first vesting for which occurred on March 30, 2021. The RSUs were subject to forfeiture prior to vesting in accordance with the terms of the 2015 Plan and the award agreement. Read SEC document |
| March 30, 2024 Filed Apr 3, 2024 01:21 UTC |
Hebbelinck TruiChief Human Resources Officer
|
Tax withholdingOrdinary Shares | 5,541 | $55.94 | $309,963.54 |
DisclosureSEC source: 0001639691-24-000047 · wk-form4_1712107272.xml · nonDerivative · entry 2 Hebbelinck Trui · CIK 0001773051 · Chief Human Resources Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,779 F2 · shares: The referenced shares were withheld from distribution to satisfy tax liability. Read SEC document |
| March 30, 2024 Filed Apr 3, 2024 01:21 UTC |
Hebbelinck TruiChief Human Resources Officer
|
Exercise / conversionOrdinary Shares | 11,779 | $0.00 | $0.00 |
DisclosureSEC source: 0001639691-24-000047 · wk-form4_1712107272.xml · nonDerivative · entry 1 Hebbelinck Trui · CIK 0001773051 · Chief Human Resources Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,320 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Reporting person had vested restricted stock units (RSUs) and performance stock units (PSUs) settled in Ordinary Shares of LivaNova PLC (the Company). Read SEC document |
| March 30, 2024 Filed Apr 3, 2024 01:20 UTC | GrantStock Appreciation Rights · Derivative | 15,631 | $0.00 Strike: $55.94 | $0.00 |
DisclosureSEC source: 0001639691-24-000045 · wk-form4_1712107205.xml · derivative · entry 14 Shvartsburg Alex · CIK 0001830830 · CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,631 Underlying: Ordinary Shares · 15,631 shares Expires not disclosed F18 · derivative.exercise_date: On March 30, 2024, reporting person was granted stock appreciation rights (SARs) subject to a four-year vesting in equal annual installments, the first vesting occurring on March 30, 2025. The SARs are subject to forfeiture prior to vesting in accordance with the terms of the 2022 Plan and the award agreement. F18 · derivative.expiration_date: On March 30, 2024, reporting person was granted stock appreciation rights (SARs) subject to a four-year vesting in equal annual installments, the first vesting occurring on March 30, 2025. The SARs are subject to forfeiture prior to vesting in accordance with the terms of the 2022 Plan and the award agreement. Read SEC document |
|
| March 30, 2024 Filed Apr 3, 2024 01:20 UTC | GrantPerformance Stock Units · Derivative | 3,575 | $0.00 | $0.00 |
DisclosureSEC source: 0001639691-24-000045 · wk-form4_1712107205.xml · derivative · entry 13 Shvartsburg Alex · CIK 0001830830 · CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,575 Underlying: Ordinary Shares · 3,575 shares Expires not disclosed F14 · derivative.exercise_price: Each PSU represents a contingent right to receive one Ordinary Share of the Company in accordance with the terms of the 2022 Plan and the award agreement. F17 · derivative.exercise_date: On March 30, 2024, reporting person was granted PSUs to vest or lapse on March 30, 2027 based on how the Company's FCF for performance period 2024-2026 compares to a target determined by the 2022 Plan Administrator. The number included in column 5 of Table II reflects the target number of PSUs eligible for vesting. F17 · derivative.expiration_date: On March 30, 2024, reporting person was granted PSUs to vest or lapse on March 30, 2027 based on how the Company's FCF for performance period 2024-2026 compares to a target determined by the 2022 Plan Administrator. The number included in column 5 of Table II reflects the target number of PSUs eligible for vesting. Read SEC document |
|
| March 30, 2024 Filed Apr 3, 2024 01:20 UTC | GrantPerformance Stock Units · Derivative | 3,575 | $0.00 | $0.00 |
DisclosureSEC source: 0001639691-24-000045 · wk-form4_1712107205.xml · derivative · entry 12 Shvartsburg Alex · CIK 0001830830 · CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,575 Underlying: Ordinary Shares · 3,575 shares Expires not disclosed F14 · derivative.exercise_price: Each PSU represents a contingent right to receive one Ordinary Share of the Company in accordance with the terms of the 2022 Plan and the award agreement. F16 · derivative.exercise_date: On March 30, 2024, reporting person was granted PSUs to vest or lapse on March 30, 2027 based on how the Company's ROIC calculated for the performance period 2024-2026 compares to a target determined by the 2022 Plan Administrator. The number included in column 5 of Table II reflects the target number of PSUs eligible for vesting subject to continued service during the vesting period and the award agreement. F16 · derivative.expiration_date: On March 30, 2024, reporting person was granted PSUs to vest or lapse on March 30, 2027 based on how the Company's ROIC calculated for the performance period 2024-2026 compares to a target determined by the 2022 Plan Administrator. The number included in column 5 of Table II reflects the target number of PSUs eligible for vesting subject to continued service during the vesting period and the award agreement. Read SEC document |
|
| March 30, 2024 Filed Apr 3, 2024 01:20 UTC | GrantPerformance Stock Units · Derivative | 7,150 | $0.00 | $0.00 |
DisclosureSEC source: 0001639691-24-000045 · wk-form4_1712107205.xml · derivative · entry 11 Shvartsburg Alex · CIK 0001830830 · CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,150 Underlying: Ordinary Shares · 7,150 shares Expires not disclosed F14 · derivative.exercise_price: Each PSU represents a contingent right to receive one Ordinary Share of the Company in accordance with the terms of the 2022 Plan and the award agreement. F15 · derivative.exercise_date: On March 30, 2024, reporting person was granted PSUs to vest or lapse on March 30, 2027 based on the Company's TSR for the three-year period beginning on January 1, 2024 and ending December 31, 2026 relative to the TSR of an index of companies, as determined by the 2022 Plan Administrator. The number included in column 5 of Table II reflects the target number of PSUs eligible for vesting subject to continued service during the vesting period and the award agreement. F15 · derivative.expiration_date: On March 30, 2024, reporting person was granted PSUs to vest or lapse on March 30, 2027 based on the Company's TSR for the three-year period beginning on January 1, 2024 and ending December 31, 2026 relative to the TSR of an index of companies, as determined by the 2022 Plan Administrator. The number included in column 5 of Table II reflects the target number of PSUs eligible for vesting subject to continued service during the vesting period and the award agreement. Read SEC document |
|
| March 30, 2024 Filed Apr 3, 2024 01:20 UTC | GrantRestricted Stock Units · Derivative | 7,150 | $0.00 | $0.00 |
DisclosureSEC source: 0001639691-24-000045 · wk-form4_1712107205.xml · derivative · entry 10 Shvartsburg Alex · CIK 0001830830 · CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,150 Underlying: Ordinary Shares · 7,150 shares Expires not disclosed F7 · derivative.exercise_price: Each RSU represents a contingent right to receive one Ordinary Share of the Company in accordance with the terms of the LivaNova PLC 2022 Incentive Award Plan (the 2022 Plan) and the award agreement. F13 · derivative.exercise_date: On March 30, 2024, reporting person was granted RSUs subject to a three-year vesting schedule, the first vesting occurring on March 30, 2025. The RSUs are subject to forfeiture prior to vesting in accordance with the terms of the 2022 Plan and the award agreement. F13 · derivative.expiration_date: On March 30, 2024, reporting person was granted RSUs subject to a three-year vesting schedule, the first vesting occurring on March 30, 2025. The RSUs are subject to forfeiture prior to vesting in accordance with the terms of the 2022 Plan and the award agreement. Read SEC document |
|
| March 30, 2024 Filed Apr 3, 2024 01:20 UTC | Exercise / conversionPerformance Stock Units · Derivative | 2,581 | $0.00 | $0.00 |
DisclosureSEC source: 0001639691-24-000045 · wk-form4_1712107205.xml · derivative · entry 9 Shvartsburg Alex · CIK 0001830830 · CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 2,581 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F9 · derivative.exercise_price: Each PSU represents a contingent right to receive one Ordinary Share of the Company in accordance with the terms of the 2015 Plan and the award agreement. F12 · derivative.exercise_date: On March 30, 2021, reporting person was granted PSUs to vest or lapse on March 30, 2024 based on how the Company's Return on Investment Capital (ROIC) for fiscal year 2021 compares to a target determined by the 2015 Plan Administrator. The performance achieved was 151.30%, and the actual number of vested shares is presented as the quantity that was acquired. F12 · derivative.expiration_date: On March 30, 2021, reporting person was granted PSUs to vest or lapse on March 30, 2024 based on how the Company's Return on Investment Capital (ROIC) for fiscal year 2021 compares to a target determined by the 2015 Plan Administrator. The performance achieved was 151.30%, and the actual number of vested shares is presented as the quantity that was acquired. Read SEC document |
|
| March 30, 2024 Filed Apr 3, 2024 01:20 UTC | Exercise / conversionPerformance Stock Units · Derivative | 3,923 | $0.00 | $0.00 |
DisclosureSEC source: 0001639691-24-000045 · wk-form4_1712107205.xml · derivative · entry 8 Shvartsburg Alex · CIK 0001830830 · CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 3,923 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F9 · derivative.exercise_price: Each PSU represents a contingent right to receive one Ordinary Share of the Company in accordance with the terms of the 2015 Plan and the award agreement. F11 · derivative.exercise_date: On March 30, 2021, reporting person was granted PSUs to vest or lapse on March 30, 2024 based on the the Company's total shareholder return (TSR) for the three-year period beginning on January 1, 2021 and ending December 31, 2023 relative to the total shareholder return of a peer group of companies, as determined by the 2015 Plan Administrator. The Company's performance achieved a result of 115%, and the actual number of vested shares is presented as the quantity that was acquired. F11 · derivative.expiration_date: On March 30, 2021, reporting person was granted PSUs to vest or lapse on March 30, 2024 based on the the Company's total shareholder return (TSR) for the three-year period beginning on January 1, 2021 and ending December 31, 2023 relative to the total shareholder return of a peer group of companies, as determined by the 2015 Plan Administrator. The Company's performance achieved a result of 115%, and the actual number of vested shares is presented as the quantity that was acquired. Read SEC document |
|
| March 30, 2024 Filed Apr 3, 2024 01:20 UTC | Exercise / conversionPerformance Stock Units · Derivative | 3,412 | $0.00 | $0.00 |
DisclosureSEC source: 0001639691-24-000045 · wk-form4_1712107205.xml · derivative · entry 7 Shvartsburg Alex · CIK 0001830830 · CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 3,412 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F9 · derivative.exercise_price: Each PSU represents a contingent right to receive one Ordinary Share of the Company in accordance with the terms of the 2015 Plan and the award agreement. F10 · derivative.exercise_date: On March 30, 2021, reporting person was granted 1,706 PSUs to vest or lapse on March 30, 2024 based on how the Company's cumulative adjusted free cash flow (FCF) for fiscal year 2021 compares to a target determined by the 2015 Plan Administrator. The Company has determined that 200% of the underlying PSUs shall vest on March 30, 2024, subject to continued service during the vesting period and the award agreement. The performance achieved was 200%, and the actual number of vested shares is presented as the quantity that was acquired. F10 · derivative.expiration_date: On March 30, 2021, reporting person was granted 1,706 PSUs to vest or lapse on March 30, 2024 based on how the Company's cumulative adjusted free cash flow (FCF) for fiscal year 2021 compares to a target determined by the 2015 Plan Administrator. The Company has determined that 200% of the underlying PSUs shall vest on March 30, 2024, subject to continued service during the vesting period and the award agreement. The performance achieved was 200%, and the actual number of vested shares is presented as the quantity that was acquired. Read SEC document |
|
| March 30, 2024 Filed Apr 3, 2024 01:20 UTC | Exercise / conversionRestricted Stock Units · Derivative | 2,364 | $0.00 | $0.00 |
DisclosureSEC source: 0001639691-24-000045 · wk-form4_1712107205.xml · derivative · entry 6 Shvartsburg Alex · CIK 0001830830 · CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,092 Underlying: Ordinary Shares · 2,364 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_price: Each RSU represents a contingent right to receive one Ordinary Share of the Company in accordance with the terms of the LivaNova PLC 2022 Incentive Award Plan (the 2022 Plan) and the award agreement. F8 · derivative.exercise_date: On March 30, 2023, reporting person was granted RSUs subject to a four-year vesting in equal annual installments, the first vesting occurring on March 30, 2024. The RSUs are subject to forfeiture prior to vesting in accordance with the terms of the 2022 Plan and the award agreement. F8 · derivative.expiration_date: On March 30, 2023, reporting person was granted RSUs subject to a four-year vesting in equal annual installments, the first vesting occurring on March 30, 2024. The RSUs are subject to forfeiture prior to vesting in accordance with the terms of the 2022 Plan and the award agreement. Read SEC document |
|
| March 30, 2024 Filed Apr 3, 2024 01:20 UTC | Exercise / conversionRestricted Stock Units · Derivative | 914 | $0.00 | $0.00 |
DisclosureSEC source: 0001639691-24-000045 · wk-form4_1712107205.xml · derivative · entry 5 Shvartsburg Alex · CIK 0001830830 · CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,828 Underlying: Ordinary Shares · 914 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each RSU represents a contingent right to receive one Ordinary Share of the Company in accordance with the terms of the LivaNova PLC 2015 Incentive Award Plan (the 2015 Plan) and the award agreement. F6 · derivative.exercise_date: On March 30, 2022, reporting person was granted RSUs subject to a four-year vesting in equal annual installments, the first vesting for which occurred on March 30, 2023. The RSUs are subject to forfeiture prior to vesting in accordance with the terms of the 2015 Plan and the award agreement. F6 · derivative.expiration_date: On March 30, 2022, reporting person was granted RSUs subject to a four-year vesting in equal annual installments, the first vesting for which occurred on March 30, 2023. The RSUs are subject to forfeiture prior to vesting in accordance with the terms of the 2015 Plan and the award agreement. Read SEC document |
|
| March 30, 2024 Filed Apr 3, 2024 01:20 UTC | Exercise / conversionRestricted Stock Units · Derivative | 853 | $0.00 | $0.00 |
DisclosureSEC source: 0001639691-24-000045 · wk-form4_1712107205.xml · derivative · entry 4 Shvartsburg Alex · CIK 0001830830 · CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 853 Underlying: Ordinary Shares · 853 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each RSU represents a contingent right to receive one Ordinary Share of the Company in accordance with the terms of the LivaNova PLC 2015 Incentive Award Plan (the 2015 Plan) and the award agreement. F5 · derivative.exercise_date: On March 30, 2021, reporting person was granted RSUs subject to a four-year vesting in equal annual installments, the first vesting for which occurred on March 30, 2022. The RSUs are subject to forfeiture prior to vesting in accordance with the terms of the 2015 Plan and the award agreement. F5 · derivative.expiration_date: On March 30, 2021, reporting person was granted RSUs subject to a four-year vesting in equal annual installments, the first vesting for which occurred on March 30, 2022. The RSUs are subject to forfeiture prior to vesting in accordance with the terms of the 2015 Plan and the award agreement. Read SEC document |
|
| March 30, 2024 Filed Apr 3, 2024 01:20 UTC | Exercise / conversionRestricted Stock Units · Derivative | 705 | $0.00 | $0.00 |
DisclosureSEC source: 0001639691-24-000045 · wk-form4_1712107205.xml · derivative · entry 3 Shvartsburg Alex · CIK 0001830830 · CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 705 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each RSU represents a contingent right to receive one Ordinary Share of the Company in accordance with the terms of the LivaNova PLC 2015 Incentive Award Plan (the 2015 Plan) and the award agreement. F4 · derivative.exercise_date: On March 30, 2020, reporting person was granted RSUs subject to a four-year vesting in equal annual installments, the first vesting occurring on March 30, 2021. The RSUs were subject to forfeiture prior to vesting in accordance with the terms of the 2015 Plan and the award agreement. F4 · derivative.expiration_date: On March 30, 2020, reporting person was granted RSUs subject to a four-year vesting in equal annual installments, the first vesting occurring on March 30, 2021. The RSUs were subject to forfeiture prior to vesting in accordance with the terms of the 2015 Plan and the award agreement. Read SEC document |
|
| March 30, 2024 Filed Apr 3, 2024 01:20 UTC | Tax withholdingOrdinary Shares | 6,310 | $55.94 | $352,981.40 |
DisclosureSEC source: 0001639691-24-000045 · wk-form4_1712107205.xml · nonDerivative · entry 2 Shvartsburg Alex · CIK 0001830830 · CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,823 F2 · shares: The referenced shares were withheld from distribution to satisfy tax liability. Read SEC document |
|
| March 30, 2024 Filed Apr 3, 2024 01:20 UTC | Exercise / conversionOrdinary Shares | 14,752 | $0.00 | $0.00 |
DisclosureSEC source: 0001639691-24-000045 · wk-form4_1712107205.xml · nonDerivative · entry 1 Shvartsburg Alex · CIK 0001830830 · CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,133 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Reporting person had vested restricted stock units (RSUs) and vested performance stock units (PSUs) settled in Ordinary Shares of LivaNova PLC (the Company), GBP 1.00 par value. Read SEC document |
|
| February 29, 2024 Filed Mar 4, 2024 22:22 UTC |
KOZY WILLIAM ADirector · Chairman and CEO
|
Exercise / conversionRestricted Stock Units · Derivative | 14,512 | $54.81 | $795,402.72 |
DisclosureSEC source: 0001639691-24-000028 · wk-form4_1709590946.xml · derivative · entry 3 KOZY WILLIAM A · CIK 0001221785 · Director · Chairman and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 14,512 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each RSU represents a contingent right to receive one ordinary share of the Company, GBP 1.00 par value, in accordance with the terms of the LivaNova PLC 2022 Incentive Award Plan (the 2022 Plan) and the award agreement. F4 · derivative.exercise_date: On December 15, 2023, reporting person was granted RSUs to vest and forfeiture restrictions thereon to lapse upon the earlier of (i) the commencement of employment of a successor Chief Executive Officer and (ii) April 13, 2024, subject to Mr. Kozy's continued employment through such vesting date. F4 · derivative.expiration_date: On December 15, 2023, reporting person was granted RSUs to vest and forfeiture restrictions thereon to lapse upon the earlier of (i) the commencement of employment of a successor Chief Executive Officer and (ii) April 13, 2024, subject to Mr. Kozy's continued employment through such vesting date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.